We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$64.7B
AUM Growth
+$5.24B
Cap. Flow
+$2.36B
Cap. Flow %
3.65%
Top 10 Hldgs %
20.54%
Holding
3,821
New
235
Increased
1,962
Reduced
1,317
Closed
186

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$40.1M
2
T icon
AT&T
T
+$28M
3
FTXO icon
First Trust Nasdaq Bank ETF
FTXO
+$24.3M
4
TTE icon
TotalEnergies
TTE
+$23.7M
5
WMT icon
Walmart Inc
WMT
+$22.8M

Sector Composition

Rank Sector Weight
1 Technology 10.68%
2 Financials 9.21%
3 Healthcare 8.48%
4 Industrials 6.92%
5 Consumer Discretionary 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XHR
2351
Xenia Hotels & Resorts
XHR
$1.72B
$849K ﹤0.01%
35,802
-273
-0.8% -$6.59K
TTEK icon
2352
Tetra Tech
TTEK
$9.06B
$848K ﹤0.01%
62,065
+3,810
+7% +$50.4K
STOT icon
2353
State Street DoubleLine Short Duration Total Return Tactical ETF
STOT
$507M
$847K ﹤0.01%
17,361
+3,515
+25% +$172K
CBAY
2354
DELISTED
Cymabay Therapeutics
CBAY
$845K ﹤0.01%
76,306
+33,907
+80% +$421K
PODD icon
2355
Insulet
PODD
$10B
$844K ﹤0.01%
7,968
-29,654
-79% -$2.78M
DNR
2356
DELISTED
Denbury Resources, Inc.
DNR
$844K ﹤0.01%
136,136
-16,267
-11% -$81.1K
BNED icon
2357
Barnes & Noble Education
BNED
$435M
$840K ﹤0.01%
1,459
+700
+92% +$396K
MBIN icon
2358
Merchants Bancorp
MBIN
$2.5B
$840K ﹤0.01%
49,565
+1,968
+4% +$35.3K
BPMC
2359
DELISTED
Blueprint Medicines
BPMC
$838K ﹤0.01%
+10,736
New +$746K
FFC
2360
Flaherty & Crumrine Preferred and Income Securities Fund
FFC
$781M
$838K ﹤0.01%
46,013
+2,104
+5% +$39.9K
NOAH
2361
Noah Holdings
NOAH
$591M
$838K ﹤0.01%
19,878
+8,576
+76% +$391K
PSCC icon
2362
Invesco S&P SmallCap Consumer Staples ETF
PSCC
$41.4M
$837K ﹤0.01%
30,033
+6,411
+27% +$179K
FFBC icon
2363
First Financial Bancorp
FFBC
$3.57B
$835K ﹤0.01%
28,099
+4,667
+20% +$145K
RBLD icon
2364
First Trust Alerian US NextGen Infrastructure ETF
RBLD
$57.9M
$835K ﹤0.01%
14,752
-1,216
-8% -$67.7K
FSB
2365
DELISTED
Franklin Financial Network, Inc.
FSB
$835K ﹤0.01%
21,358
+1,275
+6% +$49.3K
SPPP
2366
Sprott Physical Platinum and Palladium Trust
SPPP
$617M
$833K ﹤0.01%
94,861
-9,475
-9% -$76.2K
RIG icon
2367
Transocean
RIG
$6.49B
$831K ﹤0.01%
59,575
+3,486
+6% +$43.3K
HRTX icon
2368
Heron Therapeutics
HRTX
$61.5M
$827K ﹤0.01%
26,127
-2,982
-10% -$111K
BMI icon
2369
Badger Meter
BMI
$3.93B
$826K ﹤0.01%
15,596
+3,366
+28% +$175K
AQUA
2370
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$825K ﹤0.01%
46,385
+4,341
+10% +$85.1K
CWH icon
2371
Camping World
CWH
$655M
$823K ﹤0.01%
38,579
+6,601
+21% +$145K
HZO icon
2372
MarineMax
HZO
$1.16B
$822K ﹤0.01%
38,669
-1,579
-4% -$33K
PCH
2373
DELISTED
PotlatchDeltic
PCH
$822K ﹤0.01%
20,065
+2,277
+13% +$108K
CVS icon
2374
CALL
CVS Health
CVS
$120B
$821K ﹤0.01%
96,700
-8,100
-8% -$579K
LOB icon
2375
Live Oak Bancshares
LOB
$1.98B
$819K ﹤0.01%
30,569
-7,230
-19% -$216K

Similar funds

Raymond James & Associates's Q3 2018 Portfolio in Review

As of Q3 2018, Raymond James & Associates held 3,821 positions worth $64.7B, up 8.8% from $59.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates deployed $2.36B of net new capital in Q3 2018, opening 235 new positions and adding to 1,962 existing holdings. Its largest new stake was State Street Communication Services Select Sector SPDR ETF: 365,478 shares worth $17.9M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Sanofi, an estimated $40.1M trimmed.

  • Raymond James & Associates's largest Q3 2018 buy was State Street Communication Services Select Sector SPDR ETF: 365,478 shares worth $17.9M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q3 2018, an estimated $155M increase.
  • Raymond James & Associates's biggest Q3 2018 reduction was Sanofi, cutting an estimated $40.1M.
  • Raymond James & Associates fully exited Abaxis Inc in Q3 2018, selling an estimated $10.5M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $64.7B portfolio in Q3 2018.
  • Raymond James & Associates opened 235 new positions and closed 186 in Q3 2018.
  • Raymond James & Associates's portfolio value rose 8.8% quarter-over-quarter to $64.7B.

Based on Raymond James & Associates's 13F filing for Q3 2018, filed 14 Nov 2018.